ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Hot Features

Registration Strip Icon for monitor Monitoree múltiples cotizaciones en tiempo real de los principales intercambios, como la Bolsa de Valores de Londres, NASDAQ, NYSE, AMEX, Bovespa y más.

AUPH Aurinia Pharmaceuticals Inc

5.36
0.00 (0.00%)
Pre Mercado
Última actualización: 03:44:21
Retrasado por 15 minutos
Nombre de la Acción Símbolo de la Acción Bolsa de Valores Tipo de Valor
Aurinia Pharmaceuticals Inc AUPH NASDAQ Acción Común
  Variación del Día (ptos.) Variación del Día (%) Último Precio Hora
0.00 0.00% 5.36 03:44:21
Precio de Apertura Precio Mínimo Precio Máximo Precio de cierre Precio Anterior
5.36
más cotizaciones de acciones »

Noticias Recientes

Fecha Hora Fuente Noticia
03/6/202417:30BWAurinia Provides Update on Proxy Statement
30/5/202405:00BWAurinia Will Attend 2024 Jefferies Global Healthcare..
22/5/202415:16EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22/5/202415:14EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22/5/202415:11EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22/5/202415:09EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22/5/202415:07EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/5/202405:00BWAnalysis Showing LUPKYNIS® is a Cost-Effective Treatment for..
09/5/202405:00BWAurinia Presents Data Reinforcing LUPKYNIS® Safety and..
07/5/202405:00BWAurinia Will Attend 2024 RBC Capital Markets Global..
02/5/202405:00BWAurinia Pharmaceuticals Reports First Quarter 2024 Financial..
01/5/202405:00BWAurinia Underscores Enduring Commitment to People Living..
30/4/202405:00BWThe U.S. Food & Drug Administration (FDA) Approves Updated..
16/4/202409:48BWUPDATE: New Aurinia Presentation Details at the 2024 Bloom..
15/4/202405:00BWAurinia Pharmaceuticals to Release First Quarter Financial..
09/4/202405:00BWAurinia Will Attend 2024 Bloom Burton & Co. Healthcare..
07/3/202415:44EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/3/202415:43EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/3/202415:42EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/3/202415:41EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29/2/202415:10EDGAR2Form 8-K - Current report
29/2/202407:30BWAurinia Receives Exemptive Relief from Canadian Securities..
27/2/202407:30BWAurinia to Participate in Upcoming Investor Healthcare..
22/2/202415:35EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22/2/202415:33EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22/2/202415:31EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22/2/202415:29EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22/2/202415:27EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22/2/202415:19EDGAR2Form 4/A - Statement of changes in beneficial ownership of..
15/2/202405:16EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
15/2/202405:06EDGAR2Form 8-K - Current report
15/2/202405:00BWAurinia Discloses 2023 Year-End Financial and Operational..
14/2/202414:27EDGAR2Form SC 13G - Statement of acquisition of beneficial..
05/2/202407:30BWAurinia Pharmaceuticals to Release 2023 Fourth Quarter and..
05/1/202405:02EDGAR2Form 8-K - Current report
05/1/202405:00BWAurinia Provides Preliminary Unaudited Fourth Quarter and..
20/12/202305:00BWAurinia Submits IND Application to US Food & Drug..
13/11/202305:00BWAurinia Pharmaceuticals Announces Collaboration Partner..
07/11/202309:30BWAurinia Presents Breadth of Data from AURORA Clinical..
02/11/202317:00BWAurinia Presents Breadth of Data at ASN 2023 Demonstrating..
02/11/202305:05EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
02/11/202305:01EDGAR2Form 8-K - Current report
02/11/202305:00BWAurinia Pharmaceuticals Reports Third Quarter and Nine..
26/10/202314:00BWAurinia Response in Support of 2023 Updated EULAR..
19/10/202309:31BWCORRECTING and REPLACING Aurinia Pharmaceuticals to Release..
19/10/202305:00BWAurinia Pharmaceuticals to Release Third Quarter Financial..
13/10/202311:00BWAurinia Pharmaceuticals Announces Presentations at American..
22/9/202315:36EDGAR2Form 4 - Statement of changes in beneficial ownership of..
21/9/202315:06EDGAR2Form 8-K - Current report
21/9/202305:00BWAurinia Board of Directors Appoints Dr. Robert T. Foster as..